Skip to main content
SpringerLink
Log in

A practical approach for the diagnosis and management of dilated cardiomyopathy

  • Symposium on Pediatric Cardiology - I
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Dilated cardiomyopathy (DCM) refers to a group of conditions of diverse etiology in which both ventricles are enlarged with reduced contractility. Certain correctable conditions associated with ventricular dysfunction can masquerade as DCM. Most of them can be identified with relatively inexpensive and readily available tests. A typical diagnostic work-up for a child with DCM also includes a number of investigations to identify the underlying cause, some of which are expensive and sophisticated. The average center in the developing world often does not have the facilities to carry out these investigations. The results of many of these investigations typically do not translate into a specific management strategy that makes a difference to prognosis. A significant number of children with DCM will eventually develop end-stage heart failure that requires cardiac transplantation with or without bridging procedures. This is an unrealistic option for the developing world. The management strategy of childhood DCM in the developing world needs to be tailored to the resources available with in a manner such that the overall prognosis is not substantially affected.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fujioka S, Kitaura Y, Deguchi H, Kawamura K, Isomura T, Suma Het al. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy.A J Coll Cardiol 2000; 36:1920–1926.

    Article  CAS  Google Scholar 

  2. Kasper ED, Agema WRP, Hutchins GMet al. The causes of dilated cardiomyopathy: A clinicopathologic review of 673 consecutive patients.J Am Coll Cardiol 1994; 23: 586–590.

    PubMed  CAS  Google Scholar 

  3. Matitiau A, Perez-Atayde A, Sanders SPet al. Infantile dilated cardiomyopathy relationof outcome to left evntricular mechanics, hemodynamics and histology at the time of presentation.Circulation 1994; 90:1310.

    PubMed  CAS  Google Scholar 

  4. Arola A, Jokinene E, Ruuskanen Oet al. Epidemiology of idiopathic cardiomyopathies in children and adolescents: a nationwide study in Finland.Am J Epidemiol 1997; 146: 385–393.

    PubMed  CAS  Google Scholar 

  5. Daubeney PEF, Nugent A, Davis AM, Wilkinson JL, Weintraub RJ. On behalf of the National Australian Cardiomyopathy Study. Incidence and outcome of childhood cardiomyopathy in Australia: results of a ten-year population-based study [abstract].J Am Coll Cardiol 1999; 33 (suppl A): 496A.

    Google Scholar 

  6. Towbin JA. Pediatric myocardial disease.Pediatr Clin North Am 1999; 46: 289–312.

    Article  PubMed  CAS  Google Scholar 

  7. The Consensus trial study group: Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study.N Engl J Med 1987; 316:1429.

    Article  Google Scholar 

  8. The SOLVD Investigators : the effect of enalapril on survival in patient with reduced left ventricular ejection fraction and congestive heart failure. NEng J Med 1991; 325–293.

  9. Gersony WM. Major advances in pediatric cardiology in the 20th century: II.Therapeutics J Pediatr 2001; 139: 328–333.

    CAS  Google Scholar 

  10. Prabhu SS, Delvi BV. Treatable cardiomyopathies.Indian J Pediatr 2000; 67: 279–282.

    PubMed  CAS  Google Scholar 

  11. Schwartz ML, Cox GF, Lin AEet al. Clinical Approach to Genetic Cardiomyopathy in Children.Circulation 1996; 94: 2021–2038.

    PubMed  CAS  Google Scholar 

  12. Ichida F, Hamamichi Y, Miyawaki Tet al. Clinical features of isolated noncompaction of the ventricular myocardium: long-term clinical course, hemodynamic properties, and genetic background.J Am Coll Cardiol 1999; 34: 233–240.

    Article  PubMed  CAS  Google Scholar 

  13. Barth PG, Wanders RJA, Vreken P. X-linked cardioskeletal myopathy and neutropenia (Barth syndrome)-MIM 302060.J Pediatr 1999; 135: 273–276.

    Article  PubMed  CAS  Google Scholar 

  14. Nigro G, Comi LI, Politano Let al. The incidence and evoluation of cardiomyopathy in Duchenne muscular dystrophy.Int J Cardiol 1990; 26: 271–277.

    Article  PubMed  CAS  Google Scholar 

  15. Towbin JA, Hejtmancik F, Brink Pet al. X-linked cardiomyopathy (XLCM): Molecular genetic evidene of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus.Circulation 1993; 87 :854–1865.

    Google Scholar 

  16. Lauer B, Niederau C, Kuhl Uet al. Cardiac troponin T in patients with clinically suspected myocarditis.J Am Coll Cardiol 1997; 30(5): 1354–1359.

    Article  PubMed  CAS  Google Scholar 

  17. Kubo N, Morimoto S, Hiramitsu Set al. Feasibility of diagnosing chronic myocarditis by endomyocardial biopsy.Heart Vessels 1997; 12:167–170.

    PubMed  CAS  Google Scholar 

  18. Pophal SG, Sigfusson G, Booth ELet al. Complications of endomyocardial biopsy in children.J Am Coll Cardiol 1999; 34: 2105–2110.

    Article  PubMed  CAS  Google Scholar 

  19. Narayan R, Menahem S, Chow CW, Dennett X. Endomyocardial biopsy in infants and children with cardiomyopathy.Clin Cardiol 1991; 14 (11): 903–907.

    Article  PubMed  CAS  Google Scholar 

  20. Webber SA, Boyle GJ, Jaffe R, Pickering RM, Beerman LB, Flicker FJ. Role of right ventricular endomyocardial biopsy in infants and children with suspected or possible myocarditis.Br Heart J 1994; 72(4): 360–363.

    Article  PubMed  CAS  Google Scholar 

  21. Mason JW, O’connel JB, Herskowitz Aet al. A clinical trial of immunosuppressive therapy for myocarditis.N Eng J Med 1995; 333: 269.

    Article  CAS  Google Scholar 

  22. Camargo PR, Snitcowsky R, da Luz PLet al. Favorable effects 350 of immunosuppressive therapy in children with delated cardiomyopathy and active myocarditis.Pediatr Cardiol 1995; 16: 61–68.

    Article  PubMed  CAS  Google Scholar 

  23. Kleinert S, Weintraub RG, Wilkinson JL, Chow CW. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression.J Heart Lung Transplant 1997; 16: 1248–1254.

    PubMed  CAS  Google Scholar 

  24. Martin AB, Webber S, Fricker JFet al. Acute myocarditis. Rapid diagnosis by PCR in children.Circulation 1994; 90: 330–339.

    PubMed  CAS  Google Scholar 

  25. Keeling PJ, Gang G, Smith Get al. Familial dilated cardiomyopathy in the United Kingdom.Br Heart j 1995; 73: 417–421.

    Article  PubMed  CAS  Google Scholar 

  26. Michels W, Moll PP, Miller FAet al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy.N Engl J Med 1992; 326: 77–82.

    Article  PubMed  CAS  Google Scholar 

  27. Mestroni L, Krajinovic M, Severini GMet al. Familial dilated cardiomyopathy.Br Heart J 1994; 72: 35–41.

    Article  Google Scholar 

  28. Bengur AR, Beekman RH, Rocchini AP, Crowley DC, Schork MA, Rosenthal A. Acute hemodynamic effets of captopril in children with a congestive or restrictive cardiomyopathy.Circulation 1991; 83: 523–527.

    PubMed  CAS  Google Scholar 

  29. Beta-blocker therapy in young children with congestive heart failure under consideration for heart transplantation.Am Heart J 1998; 136 : 19–21.

  30. Bruns LA, Chrisant MK, Lamour JMet al. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience.J Pediatr 2001; 138: 505–511.

    Article  PubMed  CAS  Google Scholar 

  31. Gachara N, Prabhakaran S, Srinivas S, Farzana F, Krishnan U, Shah MJ. Efficacy and safety of carvedilol in infants with dilated cardiomyopathy: a preliminary report.Indian Heart J 2001; 53(1): 74–78.

    PubMed  CAS  Google Scholar 

  32. Karpati G, Carpenter S, Engel AGet al. The syndrome of systemic carnitine deficiency: clinical, morphologic, biochemica, and pathophysiologic features.Neurology 1975; 25:16–24.

    PubMed  CAS  Google Scholar 

  33. Rebouche CJ, Engel AG. Carnitine metabolism and deficiency syndromes.Mayo Clin Proc. 1983; 58: 533–540.

    PubMed  CAS  Google Scholar 

  34. Helton E, Darragh R, Francis Pet al. Metabolic Aspects of Myocardial Disease and a Role for L-Carnitine in the Treatment of Childhood Cardiomyopathy.Pediatrics 2000; 105:1260–1270.

    PubMed  CAS  Google Scholar 

  35. Kothari SS, Sharma M. L-carnitine in children with idiopathic dilated cardiomyopathy.Indian Heart J 1998; 50: 59–61.

    PubMed  CAS  Google Scholar 

  36. Drucker NA, Colan SD, Lewis ABet al. Gamma-globulin treatment of acute myocarditis in the pediatric population.Circulation 1994; 89: 252.

    PubMed  CAS  Google Scholar 

  37. Batista RJ. Reduction ventriculoplasty.Z Kardiol 2001; 90:35–37.

    Article  PubMed  Google Scholar 

  38. Gradinac S, Jovanovic I, Dukic Met al. Partial left ventriculectomy in a two-year-old girl with dilated cardiomyopathy.J Heart lung Transplant 1999; 18: 610.

    Article  Google Scholar 

  39. Hosenpud JD, Novick RJ, Breen TJ, Daily OP. The Registry of the International Society for Heart and Lung Transplantation: eleventh official report-1994.J Heart Lung Transplant 1994; 13: 561–570.

    PubMed  CAS  Google Scholar 

  40. Taliercio CP, Seward JB, Driscoll DJet al. Idiopathic dilated cardiomyopathy in the young: Clinical profile and natural history.J Am Coll Cardiol 1985; 6: 1126–1131.

    Article  PubMed  CAS  Google Scholar 

  41. Wiles HB, McArthur PD, Taylor ABet al. Prognostic features of children with dilated cardiomyopathy.Am J Cardiol 1991; 68: 1372–1376.

    Article  PubMed  CAS  Google Scholar 

  42. Akagi T, Benson LN, Ligthfoot NEet al. Natural history of dilated cardiomyopathy in children.Am Heart J 1991; 121: 1502–1506.

    Article  PubMed  CAS  Google Scholar 

  43. Lewis AB, Chabot BS. Outcome of infants and childlren with dilated cardiomyopathy.Am J Cardiol 1991; 68: 365–369.

    Article  PubMed  CAS  Google Scholar 

  44. Bruch M, Siddiqui, Celermajar DSet al. Dilated cardiomyopathy in children determinants of outcome.Br Heart J 1994; 72: 246–250.

    Article  Google Scholar 

  45. Kumar K, Thatia D, Saxena Aet al. Pediatrie dilated cardiomyopathy (DCM): prognosis in a developing nation is comparable to developed nations [abstract].J Am Coll Cardiol 1995; 27: 187A.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Amrita Institute of Medical Sciences, Kochi, Elamakkara PO, 682026, Kerala

    R. Krishna Kumar (Chief Pediatric Cardiologist)

Authors
  1. R. Krishna Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Krishna Kumar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, R.K. A practical approach for the diagnosis and management of dilated cardiomyopathy. Indian J Pediatr 69, 341–350 (2002). https://doi.org/10.1007/BF02723221

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02723221

Key words

Search

Navigation